Sofie
Phase 3Our vision is to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (theranostics).
Founded
2011
Focus
DiagnosticsRadiopharmaceuticals
About
Our vision is to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (theranostics).
Funding History
2Total raised: $43M
Series B$33MUndisclosedDec 15, 2022
Series A$10MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2011
LocationCulver City, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile